New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Renren Inc (NYSE:RENN), Baltic Trading Ltd (NYSE:BALT), BioScrip Inc (NASDAQ:BIOS), Advanced Semiconductor Engineering (ADR) (NYSE:ASX)
Renren Inc (NYSE:RENN) showed a volume of 1.74 million shares by the end of last trade whereas the average volume of the stock remained 2.06 million shares. The stock opened the session at $3.35 but then moved to $3.26. At that price, the stock showed a negative performance of -2.98%. Renren Inc. operates real name social networking Internet platform in the People’s Republic of China. Its platform enables its users to connect and communicate with each other, share information and user-generated content, play online games, listen to music, shop for deals and a range of other features and services. Its Renren Open Platform program allows users to access applications from third-party developers through an open application programming interface.
Will RENN Get Buyers Even After The Recent Rally? Find Out Here
Baltic Trading Ltd (NYSE:BALT) opened the session at $6.74 and closed the session at $6.15. The stock showed a negative performance of -6.96% in previous trading session. Baltic Trading Limited conducts shipping business focused on the drybulk industry spot market. The Company was formed by Genco Shipping & Trading Limited (Genco), an international drybulk shipping company. The Company’s fleet consists of two Capesize vessels, four Supramax vessels and three Handysize vessels with an aggregate carrying capacity of approximately 672,000 deadweight tons.
Has BALT Found The Bottom And Ready To Gain Momentum? Find Out Here
BioScrip Inc (NASDAQ:BIOS) opened the session at $7.33 and closed the session at $7.43. The stock showed a positive performance of 0.95% in previous trading session. Traded with volume of 1.69 million shares in the prior session and the average volume of the stock remained 1.47 million shares. The beta of the stock remained 1.45. BioScrip, Inc. (BioScrip) is a provider of pharmacy and home health services, which partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and the delivery of prescription medications and home health services. Its platform provides service capabilities and the ability to deliver clinical management services, which offers patients a community-based and home-based care environment.
Why Should Investors Buy BIOS After The Recent Gain? Just Go Here and Find Out
Advanced Semiconductor Engineering (ADR) (NYSE:ASX) the stock decreased -1.27% and finished the session at $4.65. Traded with volume of 1.67 million shares in the prior session and the average volume of the stock remained 1.17 million shares. The beta of the stock remained 1.32. Advanced Semiconductor Engineering, Inc. is principally engaged in the manufacture, assembly, processing, testing and distribution of integrated circuits (ICs). The Company provides IC assembly offerings, such as dual-in-line, plated-through-hole (PTH), flip-chip, ball-grid-array (BGA), chip scale package (CSP), quad and other package offerings; test service offerings,
Will ASX Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)